Drug Discovery

#Aptamer Group #Aptamers #Biomarkers #Drug discovery

Aptamer launches biomarker discovery service

Aptamer Group has launched its biomarker discovery service, offering researchers in pharmaceutical, biotechnology, and diagnostic development a new approach to identify and validate new disease markers.  The service integrates Aptamer’s Optimer technology with proteomic analysis to provide an unbiased, high-throughput approach to biomarker identification.   This… Read More

#News

#Drug discovery #Foundational model #Genomics #Large language model (LLM) #Machine learning #Merck #Open source

Merck shares foundation model with the research community

Merck is expanding access to TEDDY (Transformers for Enabling Drug DiscoverY), its foundation model for drug discovery, by adding it to HuggingFace, the premier platform for open-source machine learning and LLMs.  TEDDY was created in partnership with the Boston Consulting Group (BCG) AI Science Institute and is… Read More

#News

RNA
#Academic #Drug discovery #Single-cell analysis #Single-cell RNA sequencing

AI biotech company gives free access to single-cell sequencing

A new programme is offering academic researchers free access to advanced single-cell RNA sequencing to accelerate discovery across cancer and autoimmunity.  Immunai’s new academic initiative to support human immunology research is called the Immunai Grand Collaboration Initiative for Single-Cell Immune Profiling.  Through the programme, academic… Read More

#News

Cancer research
#Cancer research #Drug development #Drug discovery #Interview #START Center for Cancer Research (START) #Vodcast

New vodcast: In Conversation With Nick Slack, START Center for Cancer Research

In the In Conversation With series, a part of the free DDW podcast and vodcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this episode, Megan Thomas is in conversation with Nick Slack, Chairman and CEO of… Read More

#News

Cancer research
#Cancer research #Drug development #Drug discovery #Interview #START Center for Cancer Research (START) #Vodcast

Vodcast: In Conversation With Nick Slack, START Centre for Cancer Research

In the In Conversation With series, a part of the free DDW podcast and vodcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this episode, Megan Thomas is in conversation with Nick Slack, Chairman and CEO of… Read More

#Videos

#Business #Drug discovery

Turning Science into Business Symposium (DDW)

  The DDW Turning Science into Business Symposium will take place in the afternoon on Tuesday 4 November 2025 at the Francis Crick Institute, one of Europe’s biggest biomedical labs, in London, UK. This is a half day conference. Programme 12.30-1.15PM… Read More

#Webinars

Genomics concept
#AI / data analytics / healthtech / informatics #Drug discovery #eBook #Multi-omics

eBook: Omics-driven drug discovery

A new eBook is now available for download for free from DDW and Evotec. One of the givens of modern medicine is that a more profound understanding of the molecular complexity of disease processes will lead to more precise, personalised treatment options. Multiomics, integrating multiple types of data from… Read More

#News

#AI / data analytics / healthtech / informatics #Drug discovery #eBook #Multi-omics

Omics-driven drug discovery

One of the givens of modern medicine is that a more profound understanding of the molecular complexity of disease processes will lead to more precise, personalised treatment options. Multiomics, integrating multiple types of data from an individual participant’s biological sample, can provide a more holistic view of the molecular factors… Read More

#eBooks #Resources

#Collaboration #Drug discovery #Mergers and acquisitions #Partnership

New DDW Highlights podcast: 26 August 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The news this week has emphasised the importance of shared knowledge and expertise to the… Read More

#News

Digital technology concept
#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Webinar: AI and digital workflows reshape pharmaceutical R&D

A new FREE TO ATTEND webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News

#Artificial intelligence (AI) #Clinical trial design #Clinical trials #Drug discovery

The next generation of clinical trials with AI

Niven R Narain, President and CEO, BPGbio, looks at how biology-first Bayesian causal AI is redefining success in drug development. From using AI-based computational modelling to phase out animal testing for monoclonal antibodies1, to deploying its proprietary large language model-powered tool, Elsa, to read, write, and summarise regulatory documents—reducing review time… Read More

#Exclusive Content

#Drug discovery

Ebook: Omics-driven drug discovery

One of the givens of modern medicine is that a more profound understanding of the molecular complexity of disease processes will lead to more precise, personalised treatment options. Multiomics, integrating multiple types of data from an individual participant’s biological sample, can provide a more holistic view of the molecular factors… Read More

#eBooks

#Collaboration #Drug discovery #Mergers and acquisitions #Partnership

This week in drug discovery (18-22 August) 

News round-up for 18-22 August by DDW Senior Digital Content Editor Diana Turner. The news this week has emphasised the importance of shared knowledge and expertise to the development of new drugs, whether that is through research collaboration agreements or mergers and acquisitions, with a number of new… Read More

#News

Female researcher in a laboratory
#Antibiotic resistance #Antibiotics #Antibody-based therapeutics #Antimicrobial resistance (AMR) #Cancer research #Carbon emissions #Environmental impact #Green lab movement #Immunotherapy #Interview #Lab technology #Molecular Biology #Oncology #Sustain #T cell activation

New podcast: Strategies and challenges in drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Strategies and challenges in therapeutic development and lab practice”, which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “The inner workings of antibiotics”, “Targeting advances in immunotherapies”, and… Read More

#News

#Cell analysis #Drug discovery #Guide #Imaging #Spatial biology

Accelerate your imaging research with the updated protocols guide

The second edition of the ‘Imaging protocol handbook‘ from Thermo Fisher Scientific is now available to download for free. This handbook will help you accelerate your research by helping you plan and execute your imaging experiments. The Guide covers main procedural steps to achieve your best results. Plan and… Read More

#News

#Cell analysis #Drug discovery #Imaging #Spatial biology

Imaging protocol handbook

This imaging protocol handbook will help you accelerate your research by helping you plan and execute your imaging experiments. The Guide covers main procedural steps to achieve your best results. Plan and optimise imaging experiments with clear, step-by-step procedural guidance. Master core and advanced techniques—from cell proliferation and immunolabeling to… Read More

#Resources